Ozempic ‘microdosing’ is new weight-loss trend

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?
Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.
Two new studies suggest that the diabetes medication Ozempic may double the risk of a rare but serious condition that damages the optic nerve.
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
A study suggests that GLP-1 agonist drugs, like Ozempic, may reduce overdose risks and aid in addiction treatment. Further ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.
Ozempic, a weight-loss breakthrough with semaglutide, is revolutionizing fat reduction. Offering faster, more effective ...
Shaelyn Weaver, after struggling with weight issues due to PCOS and pre-diabetes, embarked on a significant weight loss ...